^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

VBI-002

i
Other names: VBI-002
News
Trials
Company:
Virtuoso Therap
Drug class:
CD47 inhibitor, ICAM-1 antagonist
News
Trials